Direct comparison of both structures revealed that RevTM CEA-IgG4-7B6 bound more efficiently to cancer cells than the scFv-based molecule (KD = 35.6 nM vs KD = 175.2 nM, respectively). This evidence concerns the gene CEACAM5 and cancer.